Want to join the conversation?
$AMGN said that the US FDA has approved the Repatha (evolocumab) Pushtronex system, a new, monthly single-dose administration option. Repatha, which is a cholesterol-lowering medication, is the first and only proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to offer a monthly single-dose delivery option.
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)